Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skoda, R. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Skoda, R. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

Blood, 15 December 2001, Vol. 98, No. 13, pp. 3504-3504

Some signals are more equal than others

We take it for granted that administering growth factors such as EPO or GM-CSF causes a selective increase in patients' hematocrit or granulocyte/monocyte counts, respectively. These selective effects of cytokines are in part due to lineage-restricted expression of their cognate receptors on late hematopoietic progenitors. But since multiple cytokine receptors are coexpressed on early committed progenitors and stem cells, it is conceivable that these cells can distinguish among specific incoming signals originating from different receptors and translate this information into activation of differentiation programs. If so, we would of course like to break the code in which this information is encrypted.

Although very attractive, the concept of specific instructive signaling by cytokine receptors has remained controversial. Hisakawa and colleagues (page 3618) provide evidence largely in support of an alternative permissive model. They examined the effects of a functional human GM-CSF receptor (hGM-CSFR) ectopically expressed on erythroid progenitors of transgenic mice. Due to species specificity, activation of the transgenic hGM-CSFR is entirely dependent on exogenous human ligand. Furthermore, to exclude the possibility of cross-talk with the endogenous mouse EPO receptor (EPOR), hGM-CSFR mice were crossed with EPOR knockout mice, and fetal liver cells deficient for EPOR but expressing the hGM-CSFR transgene were derived. Under these stringent conditions, hGM-CSF promoted fully differentiated CFU-Es and BFU-Es in vitro. Furthermore, increased expression of the same adult hemoglobins as in EPO-treated wild-type control cells was observed. These results argue that the EPO and hGM-CSF signals are equal and interchangeable. But detailed analysis of yolk sac cells at embryonic day 8 revealed subtle differences: only hGM-CSF was able to induce expression of adult hemoglobins in primitive erythropoietic cells, while both receptors promoted erythroid-colony formation. Thus specific signaling information may be detectable only within a particular cellular context, and hence both the instructive and permissive models may be partially correct. The next question is, What are the molecular features defining the cellular context?


---Radek C. Skoda
German Cancer Research Center


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Brisken, M. Socolovsky, H. F. Lodish, and R. Weinberg
The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium
PNAS, October 29, 2002; 99(22): 14241 - 14245.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skoda, R. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Skoda, R. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020